In November last year, UK approved a therapy that uses the CRISPR gene editing tool to treat sickle cell disease and β-thalassaemia.
Questions about historic approval of a CRISPR-based medicine
Posted in bioengineering, biotech/medical
Posted in bioengineering, biotech/medical
In November last year, UK approved a therapy that uses the CRISPR gene editing tool to treat sickle cell disease and β-thalassaemia.